BG Medicine
United States
acquiredacquired
acquired
Stage
2002
Founded
2
Investors
About
BG Medicine develops and markets molecular diagnostic tests for cardiovascular diseases, with its lead product being the FDA-approved Galectin-3® blood test that predicts risk in chronic heart failure patients.
Explore BG Medicine's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.